Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,328 | 469 | 98.0% |
| Education | $189.36 | 5 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,867 | 130 | $0 (2024) |
| Lilly USA, LLC | $886.00 | 22 | $0 (2024) |
| Janssen Biotech, Inc. | $618.40 | 37 | $0 (2024) |
| UCB, Inc. | $607.29 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $570.05 | 28 | $0 (2024) |
| Galderma Laboratories, L.P. | $490.31 | 15 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $436.09 | 21 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $397.32 | 69 | $0 (2024) |
| GENZYME CORPORATION | $384.96 | 25 | $0 (2024) |
| PFIZER INC. | $376.92 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,530 | 95 | ABBVIE INC. ($353.66) |
| 2023 | $1,677 | 83 | Lilly USA, LLC ($536.05) |
| 2022 | $2,515 | 121 | ABBVIE INC. ($1,035) |
| 2021 | $3,795 | 175 | AbbVie Inc. ($1,233) |
All Payment Transactions
474 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Dermatology | ||||||
| 12/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $1.20 | General |
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $1.56 | General |
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $69.87 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $3.60 | General |
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $1.13 | General |
| 12/03/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $21.43 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $14.89 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.91 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $1.20 | General |
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $1.20 | General |
| 11/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $16.03 | General |
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $0.95 | General |
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $13.89 | General |
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $2.87 | General |
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Immunology | ||||||
| 10/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: DERMATOLOGY | ||||||
| 10/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.18 | General |
| Category: IMMUNOLOGY | ||||||
| 10/05/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $1.73 | General |
| 10/05/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $1.27 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 440 | 1,132 | $649,529 | $37,894 |
| 2022 | 1 | 17 | 21 | $19,633 | $1,212 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 162 | $146,908 | $8,822 | 6.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 35 | 81 | $139,452 | $8,313 | 6.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 61 | 96 | $111,102 | $7,062 | 6.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 62 | 106 | $72,392 | $3,306 | 4.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 47 | 73 | $41,663 | $2,551 | 6.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 28 | 40 | $41,411 | $2,376 | 5.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $44,947 | $2,330 | 5.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 52 | 506 | $34,307 | $2,193 | 6.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 12 | 14 | $7,182 | $478.66 | 6.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 14 | 14 | $10,166 | $463.19 | 4.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 21 | $19,633 | $1,212 | 6.2% |
About Anna Liang, PHYSICIAN ASSISTANT
Anna Liang, PHYSICIAN ASSISTANT is a Physician Assistant healthcare provider based in Henderson, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/05/2019. The National Provider Identifier (NPI) number assigned to this provider is 1982241261.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anna Liang, PHYSICIAN ASSISTANT has received a total of $9,518 in payments from pharmaceutical and medical device companies, with $1,530 received in 2024. These payments were reported across 474 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($9,328).
As a Medicare-enrolled provider, Liang has provided services to 457 Medicare beneficiaries, totaling 1,153 services with total Medicare billing of $39,106. Data is available for 2 years (2022–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Henderson, NV
- Active Since 12/05/2019
- Last Updated 10/20/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1982241261
Products in Payments
- SKYRIZI (Biological) $1,708
- RINVOQ (Biological) $576.03
- DUPIXENT (Biological) $528.15
- OLUMIANT (Drug) $458.77
- HUMIRA (Biological) $442.25
- COSENTYX (Biological) $431.17
- TALTZ (Drug) $427.23
- TREMFYA (Drug) $415.62
- BOTOX (Biological) $332.55
- Enbrel (Biological) $317.02
- Bimzelx (Biological) $298.18
- EUCRISA (Drug) $239.52
- AKLIEF (Drug) $225.81
- Ilumya (Biological) $216.88
- REMICADE (Biological) $202.78
- ORACEA (Drug) $185.70
- Cimzia (Drug) $184.20
- LIBTAYO (Biological) $165.04
- OPZELURA (Drug) $146.34
- CIBINQO (Drug) $137.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Henderson
Rachel Tennis, Pa-C, PA-C
Physician Assistant — Payments: $8,011
Stephanie Shibata, Pa-C, PA-C
Physician Assistant — Payments: $7,733
Benjamin Reese, Pa-C, PA-C
Physician Assistant — Payments: $6,807
Andrea Alessi, Pa, PA
Physician Assistant — Payments: $6,647
Laurie Michlin, Apn, APN
Physician Assistant — Payments: $6,402
Daniel Salmon, Pa, PA
Physician Assistant — Payments: $6,367